Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 09, 2022 16:05 ET | Source: Vallon Pharmaceuticals Inc.

Vallon Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update

PHILADELPHIA, PA, May 09, 2022 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), (“Vallon” or the “Company”), a clinical-stage biopharmaceutical company primarily focused on the...
April 22, 2022 08:00 ET | Source: Vallon Pharmaceuticals Inc.

Vallon Pharmaceuticals Announces Review of Strategic Alternatives

Philadelphia, PA, April 22, 2022 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), (“Vallon” or the “Company”), a clinical-stage biopharmaceutical company primarily focused on the...
February 28, 2022 16:05 ET | Source: Vallon Pharmaceuticals Inc.

Vallon Pharmaceuticals Announces Appointment of Meenu Karson to Board of Directors

Global biopharmaceutical industry senior executive with over 15 years of operational leadership with transactional and capital markets experience spanning both private and public large pharma and...
February 12, 2021 15:30 ET | Source: Vallon Pharmaceuticals Inc.

Vallon Pharmaceuticals Announces Closing of Initial Public Offering

PHILADELPHIA, PA, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals Inc. (NASDAQ: VLON) (“Vallon” or the “Company”), a clinical-stage biopharmaceutical company primarily focused on the...